Archive
2023 96 97 98 99 100 101
2022 90 91 92 93 94 95
2021 84 85 86 87 88 89
2020 78 79 80 81 82 83
2019 72 73 74 75 76 77
2018 66 67 68 69 70 71
2017 60 61 62 63 64 65
2016 54 55 56 57 58 59
2015 48 49 50 51 52 53
2014 42 43 44 45 46 47
News
Submit your article
Newsletter


Issue № 90. February 2022

State Regulation in the Sphere of Developing and Producing COVID-2019 Vaccines: Comparative Analysis of Russian and Foreign Experience

Olga A. Zarayskaya, Polina S. Terekhova

Olga A. Zarayskaya
PhD, Assistant of Professor, School of Public Administration, Lomonosov Moscow State University, Moscow, Russian Federation.
E-mail: ZarayskayaOA@spa.msu.ru

Polina S. Terekhova
Student, School of Public Administration, Lomonosov Moscow State University, Moscow, Russian Federation.
E-mail: TerekhovaPS@spa.msu.ru

The article provides a comparative analysis of the experience of state regulation of developing and producing COVID-19 vaccines in the United States, the United Kingdom and the Russian Federation. Vaccine development is characterized by particular complexity, the scale of investment required, barriers to entry, and high educational requirements for scientists involved in research. It has been found that the governments of the studied countries are quite capable of keeping up with the rapidly growing pace of changes in the world (in particular, modifying vaccines due to new strains of coronavirus). Furthermore, it has been shown that developed countries, in particular the United States of America and the United Kingdom, are significantly ahead of other countries in the developing and producingCOVID-19 vaccines. The analysis also revealed the reasons for non-recognition of Russian vaccines by Western countries. As a result, measures aimed at improving the regulatory framework and infrastructure support for the effective functioning of public administration in developing and producing COVID-19 vaccines are proposed.

Keywords

COVID-19 pandemic, state measures to fight the pandemic, state regulation in developing and producing vaccines, state policy in the field of vaccine production, state policy, public administration.

DOI: 10.24412/2070-1381-2022-90-32-43

Comments:
No material published in this journal may be reproduced in print or in electronic form without a link to "E-journal. Public Administrarion".
119991, Room A-710, Shuvalovskiy building, Lomonosov Moscow State University
(27/4, Lomonosovskiy Avenue); phone: +7 (495) 930-85-71
Copyright © 2015 SPA MSU


Яндекс.Метрика